Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
Gastrointestinal Drug market report explains the definition, types, applications, major countries, and major players of the Gastrointestinal Drug market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Bayer
Perrigo
Sanofi
Teva
Xian-Janssen
Purdue Pharma
Pfizer
Abbott
Zeria?Tillotts?
GlaxoSmithKline
Jiangzhong
AstraZenec
Boehringer Ingelheim
By Type:
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
By End-User:
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Gastrointestinal Drug Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Gastrointestinal Drug Outlook to 2028- Original Forecasts
-
2.2 Gastrointestinal Drug Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Gastrointestinal Drug Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Gastrointestinal Drug Market- Recent Developments
-
6.1 Gastrointestinal Drug Market News and Developments
-
6.2 Gastrointestinal Drug Market Deals Landscape
7 Gastrointestinal Drug Raw Materials and Cost Structure Analysis
-
7.1 Gastrointestinal Drug Key Raw Materials
-
7.2 Gastrointestinal Drug Price Trend of Key Raw Materials
-
7.3 Gastrointestinal Drug Key Suppliers of Raw Materials
-
7.4 Gastrointestinal Drug Market Concentration Rate of Raw Materials
-
7.5 Gastrointestinal Drug Cost Structure Analysis
-
7.5.1 Gastrointestinal Drug Raw Materials Analysis
-
7.5.2 Gastrointestinal Drug Labor Cost Analysis
-
7.5.3 Gastrointestinal Drug Manufacturing Expenses Analysis
8 Global Gastrointestinal Drug Import and Export Analysis (Top 10 Countries)
-
8.1 Global Gastrointestinal Drug Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Gastrointestinal Drug Export by Region (Top 10 Countries) (2017-2028)
9 Global Gastrointestinal Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Gastrointestinal Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Prescription Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
9.1.2 Global OTC Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
9.2 Global Gastrointestinal Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Chronic Gastritis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Functional Dyspepsia Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Peptic Ulcer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Acute Gastroenteritis Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Gastrointestinal Drug Market Analysis and Outlook till 2022
-
10.1 Global Gastrointestinal Drug Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Gastrointestinal Drug Consumption (2017-2022)
-
10.2.2 Canada Gastrointestinal Drug Consumption (2017-2022)
-
10.2.3 Mexico Gastrointestinal Drug Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Gastrointestinal Drug Consumption (2017-2022)
-
10.3.2 UK Gastrointestinal Drug Consumption (2017-2022)
-
10.3.3 Spain Gastrointestinal Drug Consumption (2017-2022)
-
10.3.4 Belgium Gastrointestinal Drug Consumption (2017-2022)
-
10.3.5 France Gastrointestinal Drug Consumption (2017-2022)
-
10.3.6 Italy Gastrointestinal Drug Consumption (2017-2022)
-
10.3.7 Denmark Gastrointestinal Drug Consumption (2017-2022)
-
10.3.8 Finland Gastrointestinal Drug Consumption (2017-2022)
-
10.3.9 Norway Gastrointestinal Drug Consumption (2017-2022)
-
10.3.10 Sweden Gastrointestinal Drug Consumption (2017-2022)
-
10.3.11 Poland Gastrointestinal Drug Consumption (2017-2022)
-
10.3.12 Russia Gastrointestinal Drug Consumption (2017-2022)
-
10.3.13 Turkey Gastrointestinal Drug Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Gastrointestinal Drug Consumption (2017-2022)
-
10.4.2 Japan Gastrointestinal Drug Consumption (2017-2022)
-
10.4.3 India Gastrointestinal Drug Consumption (2017-2022)
-
10.4.4 South Korea Gastrointestinal Drug Consumption (2017-2022)
-
10.4.5 Pakistan Gastrointestinal Drug Consumption (2017-2022)
-
10.4.6 Bangladesh Gastrointestinal Drug Consumption (2017-2022)
-
10.4.7 Indonesia Gastrointestinal Drug Consumption (2017-2022)
-
10.4.8 Thailand Gastrointestinal Drug Consumption (2017-2022)
-
10.4.9 Singapore Gastrointestinal Drug Consumption (2017-2022)
-
10.4.10 Malaysia Gastrointestinal Drug Consumption (2017-2022)
-
10.4.11 Philippines Gastrointestinal Drug Consumption (2017-2022)
-
10.4.12 Vietnam Gastrointestinal Drug Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Gastrointestinal Drug Consumption (2017-2022)
-
10.5.2 Colombia Gastrointestinal Drug Consumption (2017-2022)
-
10.5.3 Chile Gastrointestinal Drug Consumption (2017-2022)
-
10.5.4 Argentina Gastrointestinal Drug Consumption (2017-2022)
-
10.5.5 Venezuela Gastrointestinal Drug Consumption (2017-2022)
-
10.5.6 Peru Gastrointestinal Drug Consumption (2017-2022)
-
10.5.7 Puerto Rico Gastrointestinal Drug Consumption (2017-2022)
-
10.5.8 Ecuador Gastrointestinal Drug Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Gastrointestinal Drug Consumption (2017-2022)
-
10.6.2 Kuwait Gastrointestinal Drug Consumption (2017-2022)
-
10.6.3 Oman Gastrointestinal Drug Consumption (2017-2022)
-
10.6.4 Qatar Gastrointestinal Drug Consumption (2017-2022)
-
10.6.5 Saudi Arabia Gastrointestinal Drug Consumption (2017-2022)
-
10.6.6 United Arab Emirates Gastrointestinal Drug Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Gastrointestinal Drug Consumption (2017-2022)
-
10.7.2 South Africa Gastrointestinal Drug Consumption (2017-2022)
-
10.7.3 Egypt Gastrointestinal Drug Consumption (2017-2022)
-
10.7.4 Algeria Gastrointestinal Drug Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Gastrointestinal Drug Consumption (2017-2022)
-
10.8.2 New Zealand Gastrointestinal Drug Consumption (2017-2022)
11 Global Gastrointestinal Drug Competitive Analysis
-
11.1 Bayer
-
11.1.1 Bayer Company Details
-
11.1.2 Bayer Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Bayer Gastrointestinal Drug Main Business and Markets Served
-
11.1.4 Bayer Gastrointestinal Drug Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Perrigo
-
11.2.1 Perrigo Company Details
-
11.2.2 Perrigo Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Perrigo Gastrointestinal Drug Main Business and Markets Served
-
11.2.4 Perrigo Gastrointestinal Drug Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Sanofi
-
11.3.1 Sanofi Company Details
-
11.3.2 Sanofi Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Sanofi Gastrointestinal Drug Main Business and Markets Served
-
11.3.4 Sanofi Gastrointestinal Drug Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Teva
-
11.4.1 Teva Company Details
-
11.4.2 Teva Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Teva Gastrointestinal Drug Main Business and Markets Served
-
11.4.4 Teva Gastrointestinal Drug Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Xian-Janssen
-
11.5.1 Xian-Janssen Company Details
-
11.5.2 Xian-Janssen Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Xian-Janssen Gastrointestinal Drug Main Business and Markets Served
-
11.5.4 Xian-Janssen Gastrointestinal Drug Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Purdue Pharma
-
11.6.1 Purdue Pharma Company Details
-
11.6.2 Purdue Pharma Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Purdue Pharma Gastrointestinal Drug Main Business and Markets Served
-
11.6.4 Purdue Pharma Gastrointestinal Drug Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Pfizer
-
11.7.1 Pfizer Company Details
-
11.7.2 Pfizer Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Pfizer Gastrointestinal Drug Main Business and Markets Served
-
11.7.4 Pfizer Gastrointestinal Drug Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Abbott
-
11.8.1 Abbott Company Details
-
11.8.2 Abbott Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Abbott Gastrointestinal Drug Main Business and Markets Served
-
11.8.4 Abbott Gastrointestinal Drug Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Zeria?Tillotts?
-
11.9.1 Zeria?Tillotts? Company Details
-
11.9.2 Zeria?Tillotts? Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Zeria?Tillotts? Gastrointestinal Drug Main Business and Markets Served
-
11.9.4 Zeria?Tillotts? Gastrointestinal Drug Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 GlaxoSmithKline
-
11.10.1 GlaxoSmithKline Company Details
-
11.10.2 GlaxoSmithKline Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 GlaxoSmithKline Gastrointestinal Drug Main Business and Markets Served
-
11.10.4 GlaxoSmithKline Gastrointestinal Drug Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Jiangzhong
-
11.11.1 Jiangzhong Company Details
-
11.11.2 Jiangzhong Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Jiangzhong Gastrointestinal Drug Main Business and Markets Served
-
11.11.4 Jiangzhong Gastrointestinal Drug Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 AstraZenec
-
11.12.1 AstraZenec Company Details
-
11.12.2 AstraZenec Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 AstraZenec Gastrointestinal Drug Main Business and Markets Served
-
11.12.4 AstraZenec Gastrointestinal Drug Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Boehringer Ingelheim
-
11.13.1 Boehringer Ingelheim Company Details
-
11.13.2 Boehringer Ingelheim Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Boehringer Ingelheim Gastrointestinal Drug Main Business and Markets Served
-
11.13.4 Boehringer Ingelheim Gastrointestinal Drug Product Portfolio
-
11.13.5 Recent Research and Development Strategies
12 Global Gastrointestinal Drug Market Outlook by Types and Applications to 2028
-
12.1 Global Gastrointestinal Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Prescription Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global OTC Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Gastrointestinal Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Chronic Gastritis Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Functional Dyspepsia Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Peptic Ulcer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Acute Gastroenteritis Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Gastrointestinal Drug Market Analysis and Outlook to 2028
-
13.1 Global Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.2.2 Canada Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.2.3 Mexico Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.3.2 UK Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.3.3 Spain Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.3.4 Belgium Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.3.5 France Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.3.6 Italy Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.3.7 Denmark Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.3.8 Finland Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.3.9 Norway Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.3.10 Sweden Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.3.11 Poland Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.3.12 Russia Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.3.13 Turkey Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.4.2 Japan Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.4.3 India Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.4.4 South Korea Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.4.8 Thailand Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.4.9 Singapore Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.4.11 Philippines Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.5.2 Colombia Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.5.3 Chile Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.5.4 Argentina Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.5.6 Peru Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.6.3 Oman Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.6.4 Qatar Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.7.2 South Africa Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.7.3 Egypt Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.7.4 Algeria Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Gastrointestinal Drug Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Gastrointestinal Drug Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Gastrointestinal Drug
-
Figure of Gastrointestinal Drug Picture
-
Table Global Gastrointestinal Drug Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Gastrointestinal Drug Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Prescription Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Global OTC Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Gastritis Consumption and Growth Rate (2017-2022)
-
Figure Global Functional Dyspepsia Consumption and Growth Rate (2017-2022)
-
Figure Global Peptic Ulcer Consumption and Growth Rate (2017-2022)
-
Figure Global Acute Gastroenteritis Consumption and Growth Rate (2017-2022)
-
Figure Global Gastrointestinal Drug Consumption by Country (2017-2022)
-
Table North America Gastrointestinal Drug Consumption by Country (2017-2022)
-
Figure United States Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Canada Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Mexico Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Gastrointestinal Drug Consumption by Country (2017-2022)
-
Figure Germany Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure UK Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Spain Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Belgium Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure France Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Italy Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Denmark Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Finland Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Norway Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Sweden Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Poland Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Russia Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Turkey Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Table APAC Gastrointestinal Drug Consumption by Country (2017-2022)
-
Figure China Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure India Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Thailand Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Singapore Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Philippines Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Table South America Gastrointestinal Drug Consumption by Country (2017-2022)
-
Figure Brazil Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Colombia Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Chile Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Argentina Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Peru Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Table GCC Gastrointestinal Drug Consumption by Country (2017-2022)
-
Figure Bahrain Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Oman Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Qatar Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Table Africa Gastrointestinal Drug Consumption by Country (2017-2022)
-
Figure Nigeria Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure South Africa Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Egypt Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure Algeria Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Table Oceania Gastrointestinal Drug Consumption by Country (2017-2022)
-
Figure Australia Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Gastrointestinal Drug Consumption and Growth Rate (2017-2022)
-
Table Bayer Company Details
-
Table Bayer Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Gastrointestinal Drug Main Business and Markets Served
-
Table Bayer Gastrointestinal Drug Product Portfolio
-
Table Perrigo Company Details
-
Table Perrigo Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Perrigo Gastrointestinal Drug Main Business and Markets Served
-
Table Perrigo Gastrointestinal Drug Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Gastrointestinal Drug Main Business and Markets Served
-
Table Sanofi Gastrointestinal Drug Product Portfolio
-
Table Teva Company Details
-
Table Teva Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Gastrointestinal Drug Main Business and Markets Served
-
Table Teva Gastrointestinal Drug Product Portfolio
-
Table Xian-Janssen Company Details
-
Table Xian-Janssen Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Xian-Janssen Gastrointestinal Drug Main Business and Markets Served
-
Table Xian-Janssen Gastrointestinal Drug Product Portfolio
-
Table Purdue Pharma Company Details
-
Table Purdue Pharma Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Purdue Pharma Gastrointestinal Drug Main Business and Markets Served
-
Table Purdue Pharma Gastrointestinal Drug Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Gastrointestinal Drug Main Business and Markets Served
-
Table Pfizer Gastrointestinal Drug Product Portfolio
-
Table Abbott Company Details
-
Table Abbott Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Gastrointestinal Drug Main Business and Markets Served
-
Table Abbott Gastrointestinal Drug Product Portfolio
-
Table Zeria?Tillotts? Company Details
-
Table Zeria?Tillotts? Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zeria?Tillotts? Gastrointestinal Drug Main Business and Markets Served
-
Table Zeria?Tillotts? Gastrointestinal Drug Product Portfolio
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Gastrointestinal Drug Main Business and Markets Served
-
Table GlaxoSmithKline Gastrointestinal Drug Product Portfolio
-
Table Jiangzhong Company Details
-
Table Jiangzhong Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jiangzhong Gastrointestinal Drug Main Business and Markets Served
-
Table Jiangzhong Gastrointestinal Drug Product Portfolio
-
Table AstraZenec Company Details
-
Table AstraZenec Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZenec Gastrointestinal Drug Main Business and Markets Served
-
Table AstraZenec Gastrointestinal Drug Product Portfolio
-
Table Boehringer Ingelheim Company Details
-
Table Boehringer Ingelheim Gastrointestinal Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Gastrointestinal Drug Main Business and Markets Served
-
Table Boehringer Ingelheim Gastrointestinal Drug Product Portfolio
-
Figure Global Prescription Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global OTC Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Gastritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Functional Dyspepsia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Peptic Ulcer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acute Gastroenteritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastrointestinal Drug Consumption Forecast by Country (2022-2028)
-
Table North America Gastrointestinal Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gastrointestinal Drug Consumption Forecast by Country (2022-2028)
-
Figure Germany Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Gastrointestinal Drug Consumption Forecast by Country (2022-2028)
-
Figure China Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Gastrointestinal Drug Consumption Forecast by Country (2022-2028)
-
Figure Brazil Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Gastrointestinal Drug Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Gastrointestinal Drug Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Gastrointestinal Drug Consumption Forecast by Country (2022-2028)
-
Figure Australia Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)
-
